- $75.19m
- $94.88m
- $44.30m
- 30
- 37
- 49
- 32
Annual income statement for Roadzen, fiscal year end - March 31st, USD millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Revenue | ||||
| Total Revenue | 9.99 | 13.6 | 46.7 | 44.3 |
| Cost of Revenue | ||||
| Gross Profit | 5.18 | 8.15 | 28.6 | 25.5 |
| Selling / General / Administrative Expenses | ||||
| Research And Development | ||||
| Depreciation and Amortization | ||||
| Unusual Expense / Income | ||||
| Total Operating Expenses | 16.2 | 26 | 126 | 106 |
| Operating Profit | -6.24 | -12.5 | -79 | -62.1 |
| Total Net Non Operating Interest Income / Expense | ||||
| Total Net Non Operating Interest Income / Expense | ||||
| Other Net Non Operating Costs | ||||
| Net Income Before Taxes | -9.78 | -14.2 | -99.9 | -73.1 |
| Provision for Income Taxes | ||||
| Net Income After Taxes | -9.81 | -14.2 | -99.9 | -73.1 |
| Minority Interest | ||||
| Net Income Before Extraordinary Items | ||||
| Net Income | -9.74 | -14 | -99.7 | -72.9 |
| Adjustments to Net Income | ||||
| Income Available to Common Shareholders Excluding Extraordinary Items | ||||
| Income Available to Common Shareholders Including Extraordinary Items | ||||
| Diluted Net Income | -9.83 | -14.1 | -99.7 | -72.9 |
| Diluted Weighted Average Shares | ||||
| Basic EPS Including Extraordinary Items | ||||
| Diluted EPS Including Extraordinary Items | ||||
| Diluted EPS Excluding Extraordinary Items | ||||
| Normalised Income Before Taxes | ||||
| Normalised Income After Taxes | ||||
| Normalised Income Available to Common Shareholders | ||||
| Diluted Normalised EPS | -0.144 | -0.198 | -1.44 | -1.03 |